1. Home
  2. UG vs BAFN Comparison

UG vs BAFN Comparison

Compare UG & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • BAFN
  • Stock Information
  • Founded
  • UG 1942
  • BAFN 1999
  • Country
  • UG United States
  • BAFN United States
  • Employees
  • UG N/A
  • BAFN N/A
  • Industry
  • UG Package Goods/Cosmetics
  • BAFN Savings Institutions
  • Sector
  • UG Consumer Discretionary
  • BAFN Finance
  • Exchange
  • UG Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • UG 36.4M
  • BAFN 40.6M
  • IPO Year
  • UG N/A
  • BAFN N/A
  • Fundamental
  • Price
  • UG $7.23
  • BAFN $9.11
  • Analyst Decision
  • UG
  • BAFN
  • Analyst Count
  • UG 0
  • BAFN 0
  • Target Price
  • UG N/A
  • BAFN N/A
  • AVG Volume (30 Days)
  • UG 6.4K
  • BAFN 9.9K
  • Earning Date
  • UG 11-11-2025
  • BAFN 10-30-2025
  • Dividend Yield
  • UG 9.59%
  • BAFN 3.52%
  • EPS Growth
  • UG N/A
  • BAFN 100.65
  • EPS
  • UG 0.56
  • BAFN 1.89
  • Revenue
  • UG $10,856,174.00
  • BAFN $78,211,000.00
  • Revenue This Year
  • UG N/A
  • BAFN N/A
  • Revenue Next Year
  • UG N/A
  • BAFN N/A
  • P/E Ratio
  • UG $13.12
  • BAFN $5.14
  • Revenue Growth
  • UG N/A
  • BAFN 0.67
  • 52 Week Low
  • UG $7.25
  • BAFN $6.40
  • 52 Week High
  • UG $14.05
  • BAFN $19.75
  • Technical
  • Relative Strength Index (RSI)
  • UG 42.03
  • BAFN 43.07
  • Support Level
  • UG $7.36
  • BAFN $9.30
  • Resistance Level
  • UG $7.49
  • BAFN $9.81
  • Average True Range (ATR)
  • UG 0.15
  • BAFN 0.33
  • MACD
  • UG -0.00
  • BAFN -0.05
  • Stochastic Oscillator
  • UG 11.16
  • BAFN 0.39

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: